Compare ThredUp Inc (TDUP) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ThredUp Inc vs Tenet Healthcare Corporation — how do they compare? ThredUp Inc trades at $3.09 (market cap $415.01M), while Tenet Healthcare Corporation trades at $267.21 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is far larger — about 50.3× ThredUp Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, ThredUp Inc nearer its low. Which is the better fit depends on your goals.
| TDUP | THC | |
|---|---|---|
Market Cap | $415.01M | $20.89B |
Sector | Consumer Cyclical | Health |
52-Week High | $12.08 | $262.63 |
52-Week Low | $3.11 | $161.37 |
Enterprise Value | $413.19M | $31.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ThredUp (TDUP) trades at $3.08, down 4.64% amid a bearish technical signal. The company reported Q2 2026 revenue growth of 16.9% to $90.8 million but missed EPS estimates and cut full-year revenue guidance, triggering a sharp stock decline. Despite a high gross margin of 79.52%, the firm remains unprofitable with a net income margin of -6.65%. Analyst consensus is positive with 57% buy ratings, but recent news highlights shareholder investigations and promotional headwinds.
The outlook is clouded by near-term execution risks and persistent losses, though long-term potential exists if the company can leverage its asset-light model and AI tools to achieve profitability. Key risks include competitive pressures, macroeconomic sensitivity, and the need to improve cost management. Investors should weigh analyst optimism against the company's challenging path to sustained earnings.
Tenet Healthcare (THC) trades at $266.79, up 2.64% today, with strong technical momentum indicated by a golden cross and bullish moving averages. The stock shows robust fundamentals with a P/E of 10.03, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent news highlights Zacks' Strong Buy rating and positive Q2 2026 results, with revenue growth and raised 2026 outlook driving investor optimism.
The outlook remains positive given analyst consensus of a $281.44 price target and 81% buy ratings, though risks include policy headwinds and net cash outflows. Earnings growth and ambulatory segment strength present opportunities, but investors should monitor expense management and regulatory changes that could impact margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ThredUp Inc
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
